AMERICAN SHARED HOSPITAL SERVICES

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of report (Date of earliest event reported): April 3, 2025

AMERICAN SHARED HOSPITAL SERVICES

(Exact Name of Registrant as Specified in Its Charter)

Registrant’s telephone number, including area code: (415)788-5300

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)

Emerging growth company☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

☐

On April 4, 2025, American Shared Hospital Services (the “Company”) issued a press release announcing its financial results for the fourth quarter and year-end 2024. The full text of the press release is furnished as Exhibit 99.1 to this report. The information furnished under this Item 2.02, including the referenced exhibit, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by reference to such filing.

On April 3, 2025, the Company appointed Gary Delanois to serve as the Company’s Chief Executive Officer. Effective on that same date, Raymond Stachowiak ceased to serve in the role of Chief Executive Officer, however, he will continue to serve as the Company’s Executive Chairman of the Board and continue to perform the function of the Company’s principal executive officer. Mr. Stachowiak was appointed as Chief Executive Officer in April 2024 upon the passing of his predecessor.

Mr. Delanois has served as the Executive Vice President and Chief Operating Officer of the Company since October 14, 2024. Mr. Delanois’ biographical information, a summary of Mr. Delanois’ business experience and compensation arrangement, and other information required by Item 401 and Item 404 of Regulation S-K was included in a Current Report on Form 8-K filed by the Company with the Securities and Exchange Commission on October 18, 2024. At this time, any changes to Mr. Delanois’ compensation in connection with his appointment as Chief Executive Officer have not been determined. The Company will file an amendment to this Current Report on Form 8-K disclosing any compensation adjustments made in connection with Mr. Delanois’ appointment if and when they are determined.

(d) Exhibits.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.